Bladder/Kidney/Other Urologic Cancers Archives - Page 23 of 23 - MPR

Bladder/Kidney/Other Urologic Cancers

Complications Seen in 40 Percent of Living Liver Donors

Liver Cancer Patients Less Likely to Die on Transplant List

Liver transplantation candidates with hepatocellular carcinoma (HCC) have significantly lower 90-day odds of waitlist removal due to clinical deterioration or death compared to non-HCC candidates with similar Model for End-Stage Liver Disease (MELD) scores.

Three ‘Targeted’ Cancer Drugs Up Risk of Fatal Adverse Events

The use of vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKIs) to treat cancer is associated with an increased risk of fatal adverse events (FAEs) but there is no difference in rates of FAEs between the different VEGFR TKIs or tumor types, according to a meta-analysis.

Cancer Prevention Guidelines Updated

The American Cancer Society (ACS) Nutrition and Physical Activity Guidelines were recently updated and published in the January/February issue of CA: A Cancer Journal for Clinicians.